WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: 19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on 19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS

Mark Identification

Proof of use for 19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS

We do not have any records of a proof of use for 19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS at this moment.

Click here to add a proof of use for 19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS

Possible trademark infringements of 19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS

Basic Information about 19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS

Serial Number
86477967
Filing Date
11 Dec 2014
Registration Number
4944019
Registration Date
26 Apr 2016
Mark Drawing Code
3

Classifications

Declare the trademark use of 19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS on the blockchain with WikiTrademarks.io.

First use of 19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS anywhere
19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS was first used on 31 Oct 2014 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
044
US Codes
100; 101

Who owns 19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS?

1. Relypsa, Inc. Redwood City CA

2. Relypsa, Inc. Redwood City CA

3. Relypsa, Inc. Redwood City CA

Correspondent

Julie C. Scheipeter
Stinson LLP
7700 FORSYTH BLVD., SUITE 1100
ST. LOUIS MO 63105

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on 19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS